Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Schulz

Showing results (41-50 of 153) with videos related to

Pageof 16
Sort By:
Transplantation|May 23, 2009
Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort studyJens Gottlieb, Thomas F Schulz, Tobias Welte, et al.
European Journal of Medicinal Chemistry|July 8, 2020
Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infectionsPhiline Kirsch, Saskia C Stein, Aylin Berwanger, et al.
Journal of Medicinal Chemistry|March 20, 2019
Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8Philine Kirsch, Valentin Jakob, Kevin Oberhausen, et al.
AIDS (London, England)|April 13, 2004
Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patientsAntoni Gayà, Anna Esteve, Jordi Casabona, et al.
Frontiers in Microbiology|November 16, 2020
Brd/BET Proteins Influence the Genome-Wide Localization of the Kaposi's Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus Major Latency ProteinsRishikesh Lotke, Ulrike Schneeweiß, Marcel Pietrek, et al.
Thrombosis and Haemostasis|December 8, 2009
The contribution of systems biology and reverse genetics to the understanding of Kaposi's sarcoma-associated herpesvirus pathogenesis in endothelial cellsMichael Stürzl, Andreas Konrad, Khaled R Alkharsah, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2015
The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNAJan Hellert, Magdalena Weidner-Glunde, Joern Krausze, et al.
The Journal of General Virology|May 9, 2007
Functional characterization of the M-type K15-encoded membrane protein of Kaposi's sarcoma-associated herpesvirusLinding Wang, Melanie M Brinkmann, Marcel Pietrek, et al.
Mbio|November 29, 2022
Human Cytomegalovirus pUL11, a CD45 Ligand, Disrupts CD4 T Cell Control of Viral Spread in Epithelial CellsSamuel A Osanyinlusi, Jasmin Zischke, Roland Jacobs, et al.
ACS Chemical Biology|January 17, 2020
Discovery of Novel Latency-Associated Nuclear Antigen Inhibitors as Antiviral Agents Against Kaposi's Sarcoma-Associated HerpesvirusPhiline Kirsch, Valentin Jakob, Walid A M Elgaher, et al.
Pageof 16

Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
Transplantation|May 23, 2009
Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort studyJens Gottlieb, Thomas F Schulz, Tobias Welte, et al.
European Journal of Medicinal Chemistry|July 8, 2020
Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infectionsPhiline Kirsch, Saskia C Stein, Aylin Berwanger, et al.
Journal of Medicinal Chemistry|March 20, 2019
Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8Philine Kirsch, Valentin Jakob, Kevin Oberhausen, et al.
AIDS (London, England)|April 13, 2004
Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patientsAntoni Gayà, Anna Esteve, Jordi Casabona, et al.
Frontiers in Microbiology|November 16, 2020
Brd/BET Proteins Influence the Genome-Wide Localization of the Kaposi's Sarcoma-Associated Herpesvirus and Murine Gammaherpesvirus Major Latency ProteinsRishikesh Lotke, Ulrike Schneeweiß, Marcel Pietrek, et al.
Thrombosis and Haemostasis|December 8, 2009
The contribution of systems biology and reverse genetics to the understanding of Kaposi's sarcoma-associated herpesvirus pathogenesis in endothelial cellsMichael Stürzl, Andreas Konrad, Khaled R Alkharsah, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2015
The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNAJan Hellert, Magdalena Weidner-Glunde, Joern Krausze, et al.
The Journal of General Virology|May 9, 2007
Functional characterization of the M-type K15-encoded membrane protein of Kaposi's sarcoma-associated herpesvirusLinding Wang, Melanie M Brinkmann, Marcel Pietrek, et al.
Mbio|November 29, 2022
Human Cytomegalovirus pUL11, a CD45 Ligand, Disrupts CD4 T Cell Control of Viral Spread in Epithelial CellsSamuel A Osanyinlusi, Jasmin Zischke, Roland Jacobs, et al.
ACS Chemical Biology|January 17, 2020
Discovery of Novel Latency-Associated Nuclear Antigen Inhibitors as Antiviral Agents Against Kaposi's Sarcoma-Associated HerpesvirusPhiline Kirsch, Valentin Jakob, Walid A M Elgaher, et al.
Pageof 16